Blood Pressure Cannabis Clinical Trials Treatment 
Project CBD
MARCH 21, 2023
Risk factors span a wide range of physical and psychological conditions including concussion, smoking, certain medications, ear infection, high blood pressure, anxiety, depression, and, most commonly, age-related hearing loss. Only three of the ten found cannabis helpful for the actual auditory symptoms characterizing tinnitus.
Medicinal Marijuana Association
FEBRUARY 11, 2024
You may have heard whispers of cannabis being used to address a specific eye condition, but what does the research truly reveal about its effectiveness? The potential link between cannabis and glaucoma treatment is a topic of ongoing investigation, stirring both curiosity and caution within the medical community.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Project CBD
AUGUST 6, 2019
Harvard University scientist Staci Gruber shared encouraging results from “the first open-label to double-blind clinical trial” assessing the impact of a high- CBD , low- THC sublingual tincture in patients who experience moderate anxiety. None of the participants had been using any cannabinoid-based products prior to this study.
Veriheal
MAY 25, 2023
What was once used as an ideal anesthetic for monkeys could soon be competing with cannabis as a medical aid. Currently, the only ketamine treatment for depression that insurance will cover is esketamine (Spravato) , an FDA-approved nasal spray. In Manhattan alone, 12 clinics have already opened their doors. million by 2027.
United Patients Group
JANUARY 8, 2023
Cannabis and the Immune System. Cannabis and the Immune System. In fact, cannabis has been used for thousands of years as a medicine. Cannabis has also been used for centuries to treat gastrointestinal disorders, epilepsy, rheumatism and malaria. Cannabis has Antiviral, Antibacterial and Fungal Properties.
Project CBD
AUGUST 6, 2019
Harvard University scientist Staci Gruber shared encouraging results from “the first open-label to double-blind clinical trial” assessing the impact of a high- CBD , low- THC sublingual tincture in patients who experience moderate anxiety. None of the participants had been using any cannabinoid-based products prior to this study.
The Cannigma
MAY 1, 2023
2 3 As clinical trials around the world proceeded in the late 1960s and 1970s, patients began reporting difficulty tolerating ketamine’s unpleasant hallucinogenic and dissociative properties. Ketamine was approved by the FDA in 1970 and was immediately put to use as an important tool for war medics in the Vietnam War.
Expert insights. Personalized for you.
144 
Let's personalize your content